What Should I Plan Before Breast Augmentation Surgery?

What should I do before breast augmentation surgery?

Before surgery, build a timeline around decisions that cannot be safely improvised later: complete disclosure, surgeon-directed preparation, recovery coverage, and a realistic plan for follow-up. The U.S. Food and Drug Administration advises discussing medical history, allergies, previous surgeries, current drugs, supplements, and possible pregnancy during consultation. This is not paperwork. It is the information the surgical team uses to judge whether the plan fits the patient.

The preoperative plan should come from the operating surgeon. The American Society of Plastic Surgeons lists blood testing, medication changes as directed, smoking cessation, and avoiding aspirin and certain anti-inflammatory medicines that can increase bleeding. The distinction matters: disclose everything, but do not independently stop a prescribed medicine because an internet checklist said to do so.

Choose the facility with the same care used to choose the procedure. ASPS states that breast augmentation should take place in an accredited outpatient or ambulatory surgical center or a hospital. If the procedure is outpatient, arrange both the ride home and a person to stay the first night.

Set expectations before committing. The FDA states that breast implants are not lifetime devices and that removal or replacement becomes more likely the longer implants remain in place. That changes the question from “Do I like this result now?” to “Can I accept monitoring, complications, and the possibility of additional surgery later?”

What questions should I ask at a breast augmentation consultation?

Ask questions that convert a broad desire for augmentation into a specific, documented decision: the surgeon's experience, expected outcomes, implant type, size, shape, surface texture, placement, and the risks and benefits in your circumstances. Those are the topics the FDA explicitly identifies for consultation, and each one affects the trade-off rather than serving as a cosmetic detail.

Ask which implant is proposed and request its labeling: the patient booklet, boxed warning, and patient decision checklist. The FDA says the checklist is meant to be reviewed and signed by both the patient and implanting physician after questions have been answered satisfactorily. A useful consultation produces documents you can reread, not merely reassuring conversation.

• What experience do you have with the procedure and the proposed approach?
• Which implant type, size, shape, texture, and placement are being recommended, and why?
• What outcome is reasonably expected in this case, and what result should not be expected?
• Which complications are relevant here, including reoperation, implant removal, rupture or deflation, pain, scarring, infection, and asymmetry?
• What follow-up, screening, and future costs could arise, particularly for silicone gel-filled implants?

The hard question is revision. According to the FDA's breast implant considerations, complications and reoperations can occur, and people with silicone gel-filled implants may be advised to obtain MRI or ultrasound screening for rupture and other complications. Those screening costs may not be covered by insurance. A decision is more realistic when future maintenance is treated as part of the procedure, not an inconvenient footnote.

Ask how the practice will document the device after surgery. The FDA says the physician should provide a patient device card containing identifying information for each implant. Keep it with other important health records; it gives future clinicians a concrete starting point.

Which medications and supplements should I tell my surgeon about?

Tell the surgeon about every prescription medicine, over-the-counter medicine, herbal product, dietary supplement, allergy, prior surgery, medical condition, possible pregnancy, and all nicotine or tobacco exposure. The FDA's instruction is unusually direct because an incomplete list can obscure factors that affect anesthesia, bleeding, healing, or the choice to proceed.

Nicotine disclosure deserves plain language. FDA labeling identifies active smoking or former smoking as a factor that can increase the risk of a poor surgical outcome, alongside conditions that affect healing or clotting, reduced breast-tissue blood supply, and immunosuppressive medicines such as steroids and chemotherapy drugs. This is a safety discussion, not a test of whether someone can provide the “right” answer.

The research gives the reason. A systematic review and meta-analysis of 60 observational studies found that, in cosmetic surgery, continued tobacco exposure was associated with a combined odds ratio of 2.3 for surgical-site infection and 2.5 for delayed wound healing. A separate systematic review of smoking cessation in plastic surgery concluded that four weeks of total smoking cessation before surgery and continuation until primary wound healing, approximately two weeks, appears to optimize surgical conditions. The review also reported published preoperative recommendations ranging from three to eight weeks.

Do not turn that evidence into self-prescribing. Tell the surgeon if you use cigarettes, vaping products, nicotine replacement, or any other nicotine-containing product, then follow the practice's timeline. The same rule applies to aspirin, anti-inflammatory medicines, supplements, and prescribed drugs: disclose first, change use only when the operating team directs it.

Finally, make room for an uncomplicated recovery rather than assuming the procedure ends at discharge. ASPS says patients are typically discharged after about one hour of monitoring once stable. Acute pain typically subsides after one to five days, but soreness and swelling can continue for weeks, and bleeding into the implant pockets is possible during the first several days. Arrange help accordingly, and follow the surgeon's instructions for activity, dressings, incision care, support garments, prescriptions, and follow-up.

The practical principle is simple: a good pre-surgery plan reduces avoidable uncertainty without pretending surgery has no uncertainty. Ask for the evidence, disclose the full record, secure recovery support, and decide only after the long-term obligations are as clear as the immediate result.